Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2005 (Vol. 25, No. 1)

Druggability: Prime Real Estate of the Genome

Translating Clinically Relevant Genes into Good Quality Drugs

  • There are numerous steps between the mapping of the genome and the development of a drug for a particular disease. Someone must sift through the data, identify potential target genes, screen and validate those targets, then find compounds which antagonize them. In the post-genomic era, strategies for doing ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.